المؤلفون: Atallah A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Grossman A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Nauman RW; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Paré JF; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Khan A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Siemens DR; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.; Department of Urology, Queen's University, Kingston, Ontario, Canada., Cotechini T; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Graham CH; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.; Department of Urology, Queen's University, Kingston, Ontario, Canada.

المصدر: International journal of cancer [Int J Cancer] 2024 Jul 15; Vol. 155 (2), pp. 352-364. Date of Electronic Publication: 2024 Mar 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/immunology , Urinary Bladder Neoplasms*/therapy , Urinary Bladder Neoplasms*/drug therapy , Tumor Microenvironment*/immunology , BCG Vaccine*/immunology , BCG Vaccine*/administration & dosage , BCG Vaccine*/therapeutic use , Immunotherapy*/methods, Animals ; Mice ; Female ; Administration, Intravesical ; Mice, Inbred C57BL ; T-Lymphocytes, Cytotoxic/immunology ; Humans ; Disease Models, Animal ; Immunity, Innate/immunology ; Cell Line, Tumor ; Immunologic Memory/immunology ; Myeloid-Derived Suppressor Cells/immunology ; Trained Immunity

المؤلفون: Abou Chakra M; Department of Urology, University of Iowa, Iowa City, Iowa., Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Brown ES; Department of Urology, University of Iowa, Iowa City, Iowa., Du GJ; Department of Urology, University of Iowa, Iowa City, Iowa., O'Donnell MA; Department of Urology, University of Iowa, Iowa City, Iowa.

المصدر: Urology practice [Urol Pract] 2024 Jul; Vol. 11 (4), pp. 613-623. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101635343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-0787 (Electronic) Linking ISSN: 23520779 NLM ISO Abbreviation: Urol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology, Humans ; Administration, Intravesical ; Neoplasm Invasiveness ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Ambulatory Care Facilities/organization & administration

المؤلفون: Obireddy SR; Department of Chemistry, Sri Krishnadevaraya University, Ananthapur, India.; Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Zhejiang, China., Lai WF; Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Zhejiang, China.; School of Food Science and Nutrition, University of Leeds, Leeds, UK.

المصدر: Current opinion in urology [Curr Opin Urol] 2024 Jul 01; Vol. 34 (4), pp. 227-235. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9200621 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-6586 (Electronic) Linking ISSN: 09630643 NLM ISO Abbreviation: Curr Opin Urol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/therapy , Drug Delivery Systems*/methods, Humans ; Administration, Intravesical ; Immunotherapy/methods ; Antineoplastic Agents/administration & dosage ; Animals ; Nanoparticles/administration & dosage

المؤلفون: Mahant R; Assistant Professor, Department of General Surgery, NSCB Medical College, Jabalpur, MP, India., Solanki FS; Associate Professor, Urology, NSCB Super Specialty Hospital, NSCB Medical College, Jabalpur, MP, India., Tiwari C; Assistant Professor, Department of General Surgery, NSCB Medical College, Jabalpur, MP, India., Lokhande A; Senior Resident, Department of General Surgery, NSCB Medical College, Jabalpur, MP, India., Sharma DB; Professor, Department of General Surgery, NSCB Medical College, Jabalpur, MP, India., Sharma D; Professor and HOD, Department of General Surgery, NSCB Medical College, Jabalpur, MP, India.

المصدر: Tropical doctor [Trop Doct] 2024 Jul; Vol. 54 (3), pp. 255-257. Date of Electronic Publication: 2024 Mar 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 1301706 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1133 (Electronic) Linking ISSN: 00494755 NLM ISO Abbreviation: Trop Doct Subsets: MEDLINE

مواضيع طبية MeSH: Lidocaine*/administration & dosage , Bupivacaine*/administration & dosage , Heparin*/administration & dosage , Anesthetics, Local*/administration & dosage , Cystitis, Interstitial*/drug therapy, Humans ; Middle Aged ; Administration, Intravesical ; Female ; Treatment Outcome ; Adult ; Male ; Aged ; Steroids/administration & dosage ; Steroids/therapeutic use ; Drug Therapy, Combination

المؤلفون: McElree IM; Carver College of Medicine, University of Iowa, Iowa City, IA., Mott SL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA., Hougen HY; Department of Urology, University of Iowa, Iowa City, IA., Packiam VT; Department of Urology, University of Iowa, Iowa City, IA., O'Donnell MA; Department of Urology, University of Iowa, Iowa City, IA; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA., Steinberg RL; Department of Urology, University of Iowa, Iowa City, IA. Electronic address: Ryan-steinberg@uiowa.edu.

المصدر: Urologic oncology [Urol Oncol] 2024 Jul; Vol. 42 (7), pp. 221.e9-221.e16. Date of Electronic Publication: 2024 Apr 11.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gemcitabine* , Deoxycytidine*/analogs & derivatives , Deoxycytidine*/administration & dosage , Deoxycytidine*/therapeutic use , Docetaxel*/administration & dosage , Docetaxel*/therapeutic use , BCG Vaccine*/therapeutic use , BCG Vaccine*/administration & dosage , Carcinoma in Situ*/drug therapy , Carcinoma in Situ*/pathology, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Aged, 80 and over ; Administration, Intravesical ; Treatment Outcome

المؤلفون: Karaburun MC; Department of Urology, Acıpayam State Hospital, Denizli, Turkey.; Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey., Kuz ED; Department of Pathology, Faculty of Medicine, Ankara University, Ankara, Turkey., Akpınar Ç; Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey.; Department of Urology, Ankara Etlik City Hospital, Ankara, Turkey., Obaid K; Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey., Göğüş C; Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey., Kiremitci S; Department of Pathology, Faculty of Medicine, Ankara University, Ankara, Turkey., Enneli D; Department of Pathology, Faculty of Medicine, Ankara University, Ankara, Turkey., Baltacı S; Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey., Süer E; Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey.

المصدر: The Journal of urology [J Urol] 2024 Jul; Vol. 212 (1), pp. 104-113. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/mortality , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/therapy , BCG Vaccine*/therapeutic use , BCG Vaccine*/administration & dosage , Neoplasm Grading* , Carcinoma, Transitional Cell*/pathology , Carcinoma, Transitional Cell*/mortality , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/therapy , Adjuvants, Immunologic*/therapeutic use, Humans ; Male ; Retrospective Studies ; Female ; Aged ; Middle Aged ; Administration, Intravesical ; Neoplasm Invasiveness ; Aged, 80 and over ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/pathology ; Progression-Free Survival ; Survival Rate

المؤلفون: Patel SH; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Gabrielson AT; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Chan S; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Schwartz D; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Collins C; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Singla N; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Trock B; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Bivalacqua TJ; Department of Urology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Hahn N; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Kates MR; James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

المصدر: The Journal of urology [J Urol] 2024 Jul; Vol. 212 (1), pp. 95-103. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Deoxycytidine*/analogs & derivatives , Deoxycytidine*/administration & dosage , Gemcitabine* , Docetaxel*/administration & dosage , BCG Vaccine*/administration & dosage , BCG Vaccine*/therapeutic use , BCG Vaccine*/adverse effects , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/pathology, Humans ; Administration, Intravesical ; Male ; Female ; Aged ; Middle Aged ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Neoplasm Invasiveness ; Aged, 80 and over ; Adjuvants, Immunologic/administration & dosage ; Adjuvants, Immunologic/adverse effects

المؤلفون: Narayan VM; Department of Urology, Emory University School of Medicine, Atlanta, Georgia., Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota., Alemozaffar M; Department of Urology, Southern California Permanente Medical Group, Los Angeles, California., Konety BR; Department of Urology, University of Minnesota and Allina Health Cancer Institute, Minneapolis, Minnesota., Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Gomella LG; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Bivalacqua TJ; Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Montgomery JS; Department of Urology, University of Michigan, Ann Arbor, Michigan., Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Busby JE; Cancer Centers of the Carolinas, Greenville Hospital System, Greenville, South Carolina., Poch M; Department of GU Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Crispen PL; Department of Urology, University of Florida, Gainesville, Florida., Steinberg GD; Department of Urology, Rush University, Chicago, Illinois., Schuckman AK; USC Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California., Downs TM; Department of Urology, University of Virginia, Charlottesville, Virginia., Mashni J Jr; Banner MD Anderson Cancer Center, Gilbert, Arizona., Lane BR; Division of Urology, Spectrum Health, Michigan State University College of Human Medicine, Grand Rapids, Michigan., Guzzo TJ; Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Bratslavsky G; Department of Urology, SUNY Upstate Medical University, Syracuse, New York., Karsh LI; The Urology Center of Colorado, Denver, Colorado., Woods ME; Department of Urology, Loyola University Medical Center, Maywood, Illinois., Brown G; New Jersey Urology, Bloomfield, New Jersey., Canter D; Georgia Urology, Atlanta, Georgia., Luchey A; West Virginia University Cancer Institute, Morgantown, West Virginia., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Inman BA; Division of Urology, Department of Surgery, Western University, London, Ontario, Canada., Williams MB; Urology of Virginia, Virginia Beach, Virginia., Cookson MS; Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Chang SS; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Sankin AI; Department of Urology, Montefiore Medical Center, Bronx, New York., O'Donnell MA; Department of Urology, University of Iowa, Iowa City, Iowa., Sawutz D; FKD Therapies Oy, Kuopio, Finland., Philipson R; Calliditas Therapeutics, Stockholm, Sweden., Parker NR; AI Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland., Yla-Herttuala S; AI Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland., Rehm D; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Jakobsen JS; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Juul K; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Dinney CPN; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: The Journal of urology [J Urol] 2024 Jul; Vol. 212 (1), pp. 74-86. Date of Electronic Publication: 2024 May 05.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/therapy , Urinary Bladder Neoplasms*/mortality , BCG Vaccine*/administration & dosage , BCG Vaccine*/therapeutic use, Humans ; Male ; Female ; Administration, Intravesical ; Follow-Up Studies ; Aged ; Middle Aged ; Carcinoma in Situ/pathology ; Carcinoma in Situ/therapy ; Carcinoma in Situ/drug therapy ; Neoplasm Invasiveness ; Treatment Outcome ; Adenoviridae/genetics ; Adjuvants, Immunologic/administration & dosage ; Adjuvants, Immunologic/therapeutic use ; Aged, 80 and over

المؤلفون: Brisuda A; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic. antonin.brisuda@fnmotol.cz., Horňák J; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic., Žemličková B; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic., Háček J; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic., Babjuk M; 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06, Prague 5, Czech Republic.

المصدر: International urology and nephrology [Int Urol Nephrol] 2024 Jul; Vol. 56 (7), pp. 2243-2250. Date of Electronic Publication: 2024 Feb 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2584 (Electronic) Linking ISSN: 03011623 NLM ISO Abbreviation: Int Urol Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/therapy , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/drug therapy , Hyperthermia, Induced* , Neoplasm Invasiveness*, Humans ; Female ; Male ; Aged ; Administration, Intravesical ; Middle Aged ; Carcinoma, Transitional Cell/therapy ; Carcinoma, Transitional Cell/pathology ; Carcinoma, Transitional Cell/drug therapy ; Risk Assessment ; Aged, 80 and over ; Retrospective Studies ; Treatment Outcome

المؤلفون: Lee DH; Department of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; R&D Center of Curigin Ltd., Curigin, Seoul, 04778, Republic of Korea., Yoo JK; Department of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; R&D Center of Curigin Ltd., Curigin, Seoul, 04778, Republic of Korea., Um KH; Department of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; R&D Center of Curigin Ltd., Curigin, Seoul, 04778, Republic of Korea.; Department of Regulatory Science, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea., Ha W; R&D Center of Curigin Ltd., Curigin, Seoul, 04778, Republic of Korea., Lee SM; Department of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.; Department of Regulatory Science, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea., Park J; Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea., Kye MJ; R&D Center of Curigin Ltd., Curigin, Seoul, 04778, Republic of Korea., Suh J; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Republic of Korea., Choi JW; Department of Pharmacology, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea. jinwoo.ch@khu.ac.kr.; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea. jinwoo.ch@khu.ac.kr.; R&D Center of Curigin Ltd., Curigin, Seoul, 04778, Republic of Korea. jinwoo.ch@khu.ac.kr.; Department of Regulatory Science, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea. jinwoo.ch@khu.ac.kr.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jun 18; Vol. 43 (1), pp. 170. Date of Electronic Publication: 2024 Jun 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/genetics , Urinary Bladder Neoplasms*/therapy , STAT3 Transcription Factor*/metabolism , TOR Serine-Threonine Kinases*/metabolism , TOR Serine-Threonine Kinases*/antagonists & inhibitors, Humans ; Animals ; Mice ; Administration, Intravesical ; Female ; Cell Line, Tumor ; Xenograft Model Antitumor Assays